| CTRI Number |
CTRI/2018/07/014742 [Registered on: 05/07/2018] Trial Registered Prospectively |
| Last Modified On: |
04/07/2018 |
| Post Graduate Thesis |
No |
| Type of Trial |
Observational |
|
Type of Study
|
Cohort Study |
| Study Design |
Other |
|
Public Title of Study
|
LHS4CVD A " Learning Health Systems For Cardio-Vascular Diseases" |
|
Scientific Title of Study
|
A Learning Health System For adherence to secondary prevention in Cardio-Vascular Disease in Kerala informatics and non-physician health workers- a 1 year prospective study |
| Trial Acronym |
LHS4CVD |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Jaideep C Menon |
| Designation |
Cardiologist |
| Affiliation |
Amrita Institute of Medical Sciences |
| Address |
Department of Adult Cardiology
Amrita Institute of Medical Sciences, Ponekkara, Kochi
682041 3/113 A,Janaki Mandiram, Kothakulangara,ANGAMALY Ernakulam KERALA 683572 India |
| Phone |
09447352684 |
| Fax |
04842802120 |
| Email |
menon7jc@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Jaideep C Menon |
| Designation |
Cardiologist |
| Affiliation |
Amrita Institute of Medical Sciences |
| Address |
Janaki Mandiram, Kothakulangara,ANGAMALY Janaki Mandiram, Kothakulangara,ANGAMALY
KERALA 683572 India |
| Phone |
09447352684 |
| Fax |
04842802120 |
| Email |
menon7jc@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Jaideep C Menon |
| Designation |
Cardiologist |
| Affiliation |
Amrita Institute of Medical Sciences |
| Address |
Department of Adult Cardiology, Amrita Institute of Medical Sciences, Ponekkara
Ernakulam
682041 3/113A, Janaki Mandiram, Kothakulangara,ANGAMALY Ernakulam KERALA 683572 India |
| Phone |
09447352684 |
| Fax |
04842802120 |
| Email |
menon7jc@gmail.com |
|
|
Source of Monetary or Material Support
|
| EUROPEAN UNION GRANT
- REWARD Grant agreement 339239 |
|
|
Primary Sponsor
|
| Name |
EUROPEAN COMMISSION |
| Address |
European Commission,European Research Council Executive agency, C2, COV2 Rue de la Loi 200, B-1049 Brussels, Belgium |
| Type of Sponsor |
Other [International grant] |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| Research and Information Systems for developing countries Govt of India |
Core IV B, Fourth floor, India Habitat Centre, Lodhi road, New Delhi 110003 |
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Jaideep C Menon |
AIMS, KOCHI |
DEPARTMENT OF ADULT CARDIOLOGY,AMRITA INSTITUTE OF MEDICAL SCIENCES,PONNEKKARA, KOCHI Ernakulam KERALA |
9447352684 04842802120 menon7jc@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 2 |
| Name of Committee |
Approval Status |
| IEC, Amrita Institute of Medical Sciences |
Approved |
| IEC, Amrita Institute of Medical Sciences |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
on medical management, |
|
|
Intervention / Comparator Agent
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
90.00 Year(s) |
| Gender |
Both |
| Details |
Aims to study the adherence and persistence with medicines in patients with Cardio-Vascular disease. Inclusion criterion include all patients with established CVD irrespective of age or sex. There is no intervention intended and the study is purely observational |
|
| ExclusionCriteria |
| Details |
Individuals without CVD, or individuals who cannot give a consent. |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
An Open list of random numbers |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| to study the adherence persistence patterns to medications in patients with CVD |
follow up period of 1 year |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| not applicable |
not applicable |
|
|
Target Sample Size
|
Total Sample Size="2000" Sample Size from India="2000"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
05/07/2018 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
None yet |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
ENDIRA cohort is in a population of 114,064 spread over 5 panchayats in Ernakulam district, Kerala. The investigators had previously looked at the prevalence of NCD’s including diabetes, HTN, Dyslipidemia, COPD, cancers, heart disease and stroke the details of which have been published. Behavioural habits vis a vis use of tobacco and alcohol, anxiety levels diet patterns which included type and quantity of oil and use of red meats along with anthropometric measures - Height/weight and BMI were what was measured in this population. The present study envisages looking at adherence and persistence to medication patterns, in patients with established CVD. In the ENDIRA registry 1688 patients of CVD had been identified, 1201 of heart disease and 487 of CVA. We would be identifying these individuals to look at adherence. ASHA workers who have been trained for the same would be entering details of individual patients on a Tab PC with a software developed for the same. Individual consents would be taken on consent sheets on the PC itself. Adherence and persistence is assessed from the Morisky scale for adherence. This would be the first large scale study in India assessing drug adherence in the general population. |